RBC Capital Upgrades Emerson (EMR) to Outperform

January 4, 2022 5:14 PM EST Send to a Friend
RBC Capital analyst Deane Dray upgraded Emerson (NYSE: EMR) from Sector Perform to Outperform with a price target of $116.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login